• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿索呋喃酮通过阻断肺癌细胞中的上皮-间充质转化抑制表皮生长因子诱导的细胞迁移。

Ascofuranone inhibits epidermal growth factor-induced cell migration by blocking epithelial-mesenchymal transition in lung cancer cells.

机构信息

Research Institute of Biomedical Engineering and Department of Medicine, Catholic University of Daegu School of Medicine, Daegu, 42472, Republic of Korea.

Department of Biochemistry, Dong-eui University College of Korean Medicine, Busan, 47227, Republic of Korea.

出版信息

Eur J Pharmacol. 2020 Aug 5;880:173199. doi: 10.1016/j.ejphar.2020.173199. Epub 2020 May 18.

DOI:10.1016/j.ejphar.2020.173199
PMID:32439259
Abstract

Ascofuranone, an isoprenoid antibiotic initially purified from a culture broth of Ascochyta viciae, has multiple anticancer effects. However, the impacts of ascofuranone on the epithelial-mesenchymal transition (EMT) and epidermal growth factor (EGF)-induced effects on human lung cancer cell lines have not been previously reported. Here, we show that ascofuranone exerts its anticancer effects by inhibiting the EGF-induced EMT and cell migration in human lung cancer cell lines. Ascofuranone significantly inhibited EGF-induced migration and invasion by lung cancer cells, and suppressed EGF-induced morphologic changes by regulating the expression of EMT-associated proteins. In addition, ascofuranone upregulated E-cadherin, and downregulated fibronectin, vimentin, Slug, Snail, and Twist. Inhibition of ERK/AKT/mTOR promoted EGF-induced E-cadherin downregulation and inhibited EGF-induced vimentin upregulation in response to ascofuranone, implying that inhibition of the EGF-induced EMT by ascofuranone was mediated by the ERK and AKT/mTOR pathways. Inhibition of c-Myc suppressed EGF-induced vimentin upregulation, suggesting the involvement of c-Myc. Collectively, these findings suggest that ascofuranone inhibits tumor growth by blocking the EGF-induced EMT through a regulatory mechanism involving ERK, AKT/mTOR, and c-Myc in lung cancer cells.

摘要

阿索呋喃酮,一种最初从轮枝镰孢菌发酵液中分离出来的异戊烯抗生素,具有多种抗癌作用。然而,阿索呋喃酮对上皮-间充质转化(EMT)和表皮生长因子(EGF)诱导的人肺癌细胞系的影响尚未见报道。在这里,我们表明阿索呋喃酮通过抑制 EGF 诱导的 EMT 和人肺癌细胞系的细胞迁移来发挥其抗癌作用。阿索呋喃酮显著抑制 EGF 诱导的肺癌细胞迁移和侵袭,并通过调节 EMT 相关蛋白的表达抑制 EGF 诱导的形态变化。此外,阿索呋喃酮上调 E-钙黏蛋白,下调纤连蛋白、波形蛋白、Slug、Snail 和 Twist。ERK/AKT/mTOR 的抑制促进了 EGF 诱导的 E-钙黏蛋白下调,并抑制了 EGF 诱导的波形蛋白上调,这表明阿索呋喃酮通过 ERK 和 AKT/mTOR 途径抑制 EGF 诱导的 EMT。c-Myc 的抑制抑制了 EGF 诱导的波形蛋白上调,表明 c-Myc 的参与。总之,这些发现表明,阿索呋喃酮通过阻断 EGF 诱导的 EMT 来抑制肿瘤生长,这涉及肺癌细胞中的 ERK、AKT/mTOR 和 c-Myc 的调节机制。

相似文献

1
Ascofuranone inhibits epidermal growth factor-induced cell migration by blocking epithelial-mesenchymal transition in lung cancer cells.阿索呋喃酮通过阻断肺癌细胞中的上皮-间充质转化抑制表皮生长因子诱导的细胞迁移。
Eur J Pharmacol. 2020 Aug 5;880:173199. doi: 10.1016/j.ejphar.2020.173199. Epub 2020 May 18.
2
Ascofuranone suppresses EGF-induced HIF-1α protein synthesis by inhibition of the Akt/mTOR/p70S6K pathway in MDA-MB-231 breast cancer cells.阿索呋喃酮通过抑制 Akt/mTOR/p70S6K 通路抑制 EGF 诱导的 MDA-MB-231 乳腺癌细胞中 HIF-1α 蛋白的合成。
Toxicol Appl Pharmacol. 2013 Dec 15;273(3):542-50. doi: 10.1016/j.taap.2013.09.027. Epub 2013 Oct 3.
3
Ginkgolic Acid Inhibits Invasion and Migration and TGF-β-Induced EMT of Lung Cancer Cells Through PI3K/Akt/mTOR Inactivation.银杏酸通过PI3K/Akt/mTOR失活抑制肺癌细胞的侵袭、迁移及TGF-β诱导的上皮-间质转化。
J Cell Physiol. 2017 Feb;232(2):346-354. doi: 10.1002/jcp.25426. Epub 2016 Jun 2.
4
Farnesol abrogates epithelial to mesenchymal transition process through regulating Akt/mTOR pathway.法尼醇通过调节 Akt/mTOR 通路阻断上皮间质转化过程。
Pharmacol Res. 2019 Dec;150:104504. doi: 10.1016/j.phrs.2019.104504. Epub 2019 Oct 31.
5
Ascofuranone suppresses invasion and F-actin cytoskeleton organization in cancer cells by inhibiting the mTOR complex 1 signaling pathway.灰黄霉素酮通过抑制 mTOR 复合物 1 信号通路抑制癌细胞的侵袭和 F-肌动蛋白细胞骨架组织。
Cell Oncol (Dordr). 2020 Oct;43(5):793-805. doi: 10.1007/s13402-020-00520-w. Epub 2020 Jun 2.
6
Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells.ERK 和 Akt 通路在调节前列腺癌细胞中 EGFR 介导的信号转导和迁移中的差异作用。
Oncogene. 2010 Sep 2;29(35):4947-58. doi: 10.1038/onc.2010.240. Epub 2010 Jun 21.
7
Ovalitenone Inhibits the Migration of Lung Cancer Cells via the Suppression of AKT/mTOR and Epithelial-to-Mesenchymal Transition.卵形酮通过抑制 AKT/mTOR 和上皮-间充质转化抑制肺癌细胞迁移。
Molecules. 2021 Jan 26;26(3):638. doi: 10.3390/molecules26030638.
8
Src promotes EGF-induced epithelial-to-mesenchymal transition and migration in gastric cancer cells by upregulating ZEB1 and ZEB2 through AKT.Src 通过激活 AKT 上调 ZEB1 和 ZEB2 促进表皮生长因子诱导的胃癌细胞上皮间质转化和迁移。
Cell Biol Int. 2018 Mar;42(3):294-302. doi: 10.1002/cbin.10894. Epub 2017 Nov 15.
9
Taiwan cobra cardiotoxin III suppresses EGF/EGFR-mediated epithelial-to-mesenchymal transition and invasion of human breast cancer MDA-MB-231 cells.台湾眼镜蛇心脏毒素III抑制表皮生长因子/表皮生长因子受体介导的人乳腺癌MDA-MB-231细胞上皮-间质转化及侵袭。
Toxicon. 2016 Mar 1;111:108-20. doi: 10.1016/j.toxicon.2016.01.051. Epub 2016 Jan 14.
10
Specific N-glycan alterations are coupled in epithelial-mesenchymal transition induced by EGF in GE11 epithelial cells.在GE11上皮细胞中,特定的N-聚糖改变与表皮生长因子诱导的上皮-间质转化相关联。
Cell Biol Int. 2017 Feb;41(2):124-133. doi: 10.1002/cbin.10707. Epub 2016 Dec 29.

引用本文的文献

1
Killing Two Birds with One Stone: Discovery of Dual Inhibitors of Oxygen and Fumarate Respiration in Zoonotic Parasite, Echinococcus multilocularis.一石二鸟:在人畜共患寄生虫多房棘球绦虫中发现双重氧和延胡索酸呼吸抑制剂。
Antimicrob Agents Chemother. 2023 Mar 16;67(3):e0142822. doi: 10.1128/aac.01428-22. Epub 2023 Feb 22.